INCY
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Mirum Pharmaceuticals and Incyte receive U.S. FDA approval for Atebrioz (zilurgisertib) in adults and children with fibrodysplasia ossificans progressivaSep 26, 2026
- Specialised Therapeutics expanded its partnership with Incyte to include ruxolitinib cream (Opzelura) in AustraliaSep 21, 2026
- Knight Therapeutics announced a supplemental regulatory submission in Brazil for MINJUVI (tafasitamab)Aug 28, 2026
- Opzelura cream becomes the first steroid-free topical JAK inhibitor approved in the EU for moderate atopic dermatitisJul 29, 2026
- Mirum and Incyte reported positive pivotal Phase 2 PROGRESS study results for zilurgisertib in fibrodysplasia ossificans progressivaJun 15, 2026